C4 Therapeutics amends stock option plan to allow 5% annual increase

C4 Therapeutics approved amendment No. 2 to its 2020 plan, authorizing annual share increases of up to 5%. This corporate governance update aims to provide long-term flexibility for employee compensation and retention.